{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:05:20Z","timestamp":1791234320599,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clinre.2024.102361","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T15:53:09Z","timestamp":1714578789000},"page":"102361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"48","author":[{"given":"Gang","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10308","key":"10.1016\/j.clinre.2024.102361_bib0001","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.clinre.2024.102361_bib0002","first-page":"759","article-title":"Cirrhosis: diagnosis and Management","volume":"100","author":"Smith","year":"2019","journal-title":"Am Fam Physician"},{"issue":"7","key":"10.1016\/j.clinre.2024.102361_bib0003","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17474124.2018.1481747","article-title":"Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications","volume":"12","author":"Ponziani","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102361_bib0004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/jvh.13216","article-title":"Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma","volume":"27","author":"Zeng","year":"2020","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.clinre.2024.102361_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00153-20","article-title":"Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma","volume":"5","author":"Lapidot","year":"2020","journal-title":"mSystems"},{"issue":"5","key":"10.1016\/j.clinre.2024.102361_bib0006","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2024.102361_bib0007","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/MEG.0000000000001494","article-title":"Characterisation of blood microbiota in patients with liver cirrhosis","volume":"31","author":"Kajihara","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2024.102361_bib0008","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1002\/cam4.3045","article-title":"Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma","volume":"9","author":"Zheng","year":"2020","journal-title":"Cancer Med"},{"issue":"Suppl 1","key":"10.1016\/j.clinre.2024.102361_bib0009","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.clinre.2024.102361_bib0010","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1097\/MCG.0000000000000699","article-title":"Gut microbiota and the liver: a tale of 2 cities: a narrative view in 2 acts","volume":"50","author":"Koch","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.clinre.2024.102361_bib0011","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0030-1255353","article-title":"Toll-like receptor 4 and hepatic fibrogenesis","volume":"30","author":"Pradere","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"8","key":"10.1016\/j.clinre.2024.102361_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273231","article-title":"Antibiotics and probiotics on hepatic venous pressure gradient in cirrhosis: a systematic review and a meta-analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clinre.2024.102361_bib0013","first-page":"249","article-title":"Gut microbiome-based therapeutics in liver cirrhosis: basic consideration for the next step","volume":"5","author":"Fukui","year":"2017","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102361_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.clinre.2024.102361_bib0015","doi-asserted-by":"crossref","unstructured":"Higgins J.P., Green S. Cochrane handbook for systematic reviews of interventions. 2008.","DOI":"10.1002\/9780470712184"},{"key":"10.1016\/j.clinre.2024.102361_bib0016","first-page":"366","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.clinre.2024.102361_bib0017","first-page":"355","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clinre.2024.102361_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"10.1016\/j.clinre.2024.102361_bib0019","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1478-3231.2009.02020.x","article-title":"Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study","volume":"29","author":"Tandon","year":"2009","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.clinre.2024.102361_bib0020","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/liv.12172","article-title":"Effects of the adjunctive probiotic VSL# 3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial","volume":"33","author":"Gupta","year":"2013","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.clinre.2024.102361_bib0021","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/liv.12280","article-title":"VSL# 3\u00ae probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis","volume":"33","author":"Jayakumar","year":"2013","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.clinre.2024.102361_bib0022","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/liv.12539","article-title":"Oral probiotic VSL# 3 attenuates the circulatory disturbances of patients with cirrhosis and ascites","volume":"34","author":"Rinc\u00f3n","year":"2014","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.clinre.2024.102361_bib0023","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.4254\/wjh.v14.i8.1667","article-title":"Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: a pilot randomized controlled trial","volume":"14","author":"Maslennikov","year":"2022","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2024.102361_bib0024","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/liv.13986","article-title":"Potential mechanisms linking gut microbiota and portal hypertension","volume":"39","author":"Baffy","year":"2019","journal-title":"Liver Internat"},{"issue":"39","key":"10.1016\/j.clinre.2024.102361_bib0025","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.3748\/wjg.v25.i39.5897","article-title":"Gut-liver axis signaling in portal hypertension","volume":"25","author":"Simbrunner","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.clinre.2024.102361_bib0026","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2024.102361_bib0027","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2024.102361_bib0028","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2024.102361_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-9-35","article-title":"Probiotic Lactobacillus reuteribiofilms produce antimicrobial and anti-inflammatory factors","volume":"9","author":"Jones","year":"2009","journal-title":"BMC Microbiol."},{"issue":"2","key":"10.1016\/j.clinre.2024.102361_bib0030","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/j.gastro.2006.11.022","article-title":"Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth","volume":"132","author":"Yan","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2024.102361_bib0031","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/MCG.0b013e318169c44e","article-title":"Probiotics and liver disease","volume":"42","author":"Sheth","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102361_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/874768","article-title":"Is there a role for probiotics in liver disease?","volume":"2014","author":"Lo","year":"2014","journal-title":"Scientific World J"},{"issue":"3","key":"10.1016\/j.clinre.2024.102361_bib0033","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"De Franchis","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2024.102361_bib0034","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.mcg.0000165671.25272.0f","article-title":"Beneficial effects of a probiotic VSL# 3 on parameters of liver dysfunction in chronic liver diseases","volume":"39","author":"Loguercio","year":"2005","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"10.1016\/j.clinre.2024.102361_bib0035","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1111\/1750-3841.15367","article-title":"Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: a randomized clinical trial","volume":"85","author":"Behrouz","year":"2020","journal-title":"J Food Sci"},{"issue":"7","key":"10.1016\/j.clinre.2024.102361_bib0036","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MEG.0b013e3282f5197e","article-title":"Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study","volume":"20","author":"Vleggaar","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2024.102361_bib0037","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","article-title":"Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis","volume":"48","author":"Stadlbauer","year":"2008","journal-title":"J Hepatol"},{"issue":"9613","key":"10.1016\/j.clinre.2024.102361_bib0038","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(08)60207-X","article-title":"Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Besselink","year":"2008","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.clinre.2024.102361_bib0039","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/jgh.14267","article-title":"Safety and efficacy of antibiotics among acutely decompensated cirrhosis patients","volume":"33","author":"Habib","year":"2018","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T15:56:46Z","timestamp":1717343806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2210740124000822"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102361","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102361"}}